{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:23:44Z","timestamp":1762079024567},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":6650,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1990,1]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>We have studied the effect of somatostatin analogue (SMS 201\u2010995) given as a subcutaneous injection on the growth and growth hormone secretion in seven tall children (two male; five female). SMS 201\u2010995 was given in doses of 37.5 or 50 \u03bcg on a once or twice\u2010daily regimen. Growth velocity decreased from a pretreatment median of 8.3 cm\/year (range 5.5\u201312.2) to 30 cm\/year (range 0.2\u20134.5) after 6 months treatment (Wilcoxon, <jats:italic>P<\/jats:italic>=0.02). In three of the children therapy was discontinued for the next 6 months with restoration of growth rate to pretreatment values in two of the three. Growth hormone secretion decreased as a result of SMS 201\u2010995 therapy although one child needed a twice\u2010daily regimen to achieve long\u2010term suppression. Final height measurements were reduced in four of five patients with an overall reduction between 1.1 and 6.3 cm and no change in the other. No effects of treatment on fasting glucose and insulin, glycosylated haemoglobin or serum thyroxine concentrations were observed. These preliminary studies suggest that SMS 201\u2010995 may have a role in the management of the growth of tall children but the optimum mode of administration remains to be established.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1990.tb03753.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T12:08:08Z","timestamp":1205755688000},"page":"83-91","source":"Crossref","is-referenced-by-count":24,"title":["A PRELIMINARY REPORT ON THE ROLE OF SOMATOSTATIN ANALOGUE (SMS 201\u2010995) IN THE MANAGEMENT OF CHILDREN WITH TALL STATURE"],"prefix":"10.1111","volume":"32","author":[{"given":"P. C.","family":"HINDMARSH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. J.","family":"PRINGLE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"DI SILVIO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. G. D.","family":"BROOK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-67-3-493"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5904.352"},{"key":"e_1_2_1_4_1","first-page":"90","article-title":"Hormonal treatment of familial tall stature","volume":"62","author":"Bierich J.D.","year":"1973","journal-title":"Acta Paediatrica Scandinavica"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-57-5-1031"},{"key":"e_1_2_1_6_1","volume-title":"Growth Assessment in Childhood and Adolescence","author":"Brook C.G.D.","year":"1982"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1987.tb01156.x"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-64-1-37"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)92413-6"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1987.tb01188.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1988.tb01227.x"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1988.tb03669.x"},{"key":"e_1_2_1_13_1","first-page":"61","article-title":"Failure to suppress GH secretion after 2 weeks treatment with atropine or propantheline in diabetics with proliferative retinopathy","volume":"119","author":"Hyer S.L.","year":"1988","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-60-6-1161"},{"key":"e_1_2_1_15_1","first-page":"E310","article-title":"Algorithms for the study of episodic hormone secretion","volume":"243","author":"Merriam G.R.","year":"1982","journal-title":"American Journal of Physiology"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.12.2.115"},{"key":"e_1_2_1_17_1","first-page":"9","article-title":"Long term treatment of acromegaly with Sandostatin (SMS 201\u2010995)","volume":"286","author":"Pieters G.F.F.M.","year":"1987","journal-title":"Acta Endocrinological"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00443202"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1987.tb03642.x"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-65-2-355"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-65-1-136"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1988.tb01196.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/000992288802701002"},{"key":"e_1_2_1_24_1","volume-title":"Growth at Adolescence","author":"Tanner J.M.","year":"1962"},{"key":"e_1_2_1_25_1","volume-title":"Assessment of skeletal maturitatton and prediction of adult height (TW2 method)","author":"Tanner J.M.","year":"1983"},{"key":"e_1_2_1_26_1","first-page":"108","article-title":"The effect of subcutaneous infusion versus subcutaneous injection of a somatostatin analogue (SMS 201\u2010995) on the diurnal GH profile in acromegaly","volume":"116","author":"Timsit J.","year":"1987","journal-title":"Acta Eniiocrinologica"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(75)80162-4"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.290.6473.961"},{"key":"e_1_2_1_29_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1542\/peds.76.3.355","article-title":"Do short children secrete insufficient growth hormone","volume":"76","author":"Zadik Z.","year":"1985","journal-title":"Pediatrics"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1990.tb03753.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1990.tb03753.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T14:39:26Z","timestamp":1697985566000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1990.tb03753.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,1]]}},"alternative-id":["10.1111\/j.1365-2265.1990.tb03753.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1990.tb03753.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,1]]}}}